Marius Meldgaard Justesen

Rigshospitalet

Papers

1

Total Citations

10

H-Index

1

About

Dr. Marius Meldgaard Justesen is a leading head and neck surgeon whose research focuses on advancing surgical treatments for oropharyngeal squamous cell carcinoma (OPSCC), particularly through transoral robotic surgery (TORS). His major contributions center on demonstrating that TORS combined with neck dissection can achieve excellent oncologic outcomes for early-stage OPSCC while minimizing the need for adjuvant radiotherapy or chemotherapy—sparing patients from the long-term toxicities of radiation. In his landmark 2024 study, Dr. Justesen reported a consecutive single-institution series from 2013 to 2020, showing low rates of adjuvant therapy with favorable survival outcomes, a finding that has already garnered 10 citations and is shaping clinical practice. His work is particularly impactful given the rising incidence of HPV-driven OPSCC in younger patients, where de-escalation of treatment intensity is a critical goal. By refining surgical protocols and documenting real-world outcomes, Dr. Justesen is helping to establish TORS as a safe, effective alternative to primary radiotherapy, offering patients better functional preservation and quality of life. His research continues to influence guidelines and inspire further investigation into minimally invasive approaches for head and neck cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Rigshospitalet

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago